Evidence map›Paper›PMID 42818036›Full record

ArticlebioRxiv : the preprint server for biology2026

Structural Plasticity and Ligand Promiscuity of CYP3A4 Revealed by Cryo-EM.

Anna Karen Orta, Jan-Hannes Schäfer, Galen J Correy, Jordan O Norman, Julius Pampel, Kate K Huddleston, Hugo MacDermott-Opeskin, Edward B Miller, Gabriella Reggiano, João P G L M Rodrigues and 3 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Anna Karen OrtaDepartment of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0002-8526-0383
Jan-Hannes SchäferDepartment of Integrative Structural and Computational Biology, Scripps Research, La Jolla, CA, USA.ORCID 0000-0001-8163-1629
Galen J CorreyDepartment of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0001-5155-7325
Jordan O NormanDepartment of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA 94158, USA.ORCID 0009-0008-7524-3310
Julius PampelDepartment of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0002-3153-1256
Kate K HuddlestonOpenADMET, San Francisco, CA, USA.ORCID 0000-0002-3019-901X
Hugo MacDermott-OpeskinOpenADMET, San Francisco, CA, USA.ORCID 0000-0002-7393-7457
Edward B MillerSchrödinger, Inc., New York, NY, USA.ORCID 0000-0003-1590-5788
Gabriella ReggianoSchrödinger, Inc., New York, NY, USA.ORCID 0000-0003-2311-2155
João P G L M RodriguesSchrödinger, Inc., New York, NY, USA.ORCID 0000-0001-9796-3193
Gabriel C LanderDepartment of Integrative Structural and Computational Biology, Scripps Research, La Jolla, CA, USA.ORCID 0000-0003-4921-1135
W Patrick WaltersOpenADMET, San Francisco, CA, USA.ORCID 0000-0003-2860-7958
James S FraserDepartment of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0002-5080-2859

Funding

Automated, optimized, intelligent data collection for cryo-EMR01GM143805 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI LANDER, GABRIEL C · 2021 to 2025
$4.7M
NIGMS NIH HHS R01 GM143805
6 · The paper itself

Abstract

Cytochrome P450 3A4 (CYP3A4) metabolizes roughly half of all marketed drugs, and its inhibition can cause clinically significant drug-drug interactions. The enzyme accommodates chemically diverse ligands, making binding modes and metabolic outcomes difficult to predict. Previous X-ray crystallography efforts have leveraged a truncated construct without the N-terminal segment that tethers CYP3A4 to the membrane. Here we show that the same construct assembles into a symmetric trimer that can be resolved by cryo-EM and determine structures of both unliganded and ligand-bound CYP3A4. Multiple ligands are resolved with density consistent with several mutually exclusive conformations. Protein remodeling to reshape the binding pocket is concentrated in the F/G loop, which is poorly resolved and unmodeled in many X-ray structures. These features likely underlie the poor predictive performance of co-folding methods on this target. The routine use of cryo-EM to resolve CYP3A4 ligand-bound complexes will provide the ground truth data needed to make predictive models of drug metabolism useful in practice.

Identifiers

PMID42818036
PMCPMC13622003

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.